Results 101 to 110 of about 43,221 (225)

Concurrent Treatment With Lorlatinib and Dinutuximab Beta Induced Acute Gastric Dilation in a Pediatric Patient With Neuroblastoma

open access: yes
Pediatric Blood &Cancer, Volume 73, Issue 10, October 2026.
Suna Lin   +6 more
wiley   +1 more source

A Seven‐Year Retrospective Study on the Epidemiology of Cutaneous Adverse Drug Reactions in Hospitalized Patients From Southern Iran: A Cross‐Sectional Study

open access: yesHealth Science Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Introduction Cutaneous adverse drug reactions (CADRs) represent a significant clinical challenge, ranging from mild to life‐threatening conditions such as Stevens‐Johnson syndrome (SJS) and toxic epidermal necrosis (TEN). This study aims to evaluate the epidemiological and clinical characteristics of CADRs in patients admitted to a tertiary ...
Mohammadreza Keshtkar   +5 more
wiley   +1 more source

Risk factors analysis of hypokalemia after radical resection of esophageal cancer and establishment of a nomogram risk prediction model

open access: yesFrontiers in Surgery
ObjectiveThis study aimed to explore the risk factors of hypokalemia after radical resection of esophageal cancer (EC) and establish a nomogram risk prediction model to evaluate hypokalemia risk after esophagectomy.
Guanqiang Yan   +7 more
doaj   +1 more source

Hypokalemia: A potentially life-threatening complication of tenofovir therapy

open access: yes, 2017
Tenofovir is a nucleotide analog reverse transcriptase inhibitor approved for the treatment of HIV and hepatitis B infections. It is widely prescribed and an integral part of the recommended regimens for the treatment of HIV infection in antiretroviral ...
Abhilash Koratala, Rupam Ruchi
core   +2 more sources

Atrioventricular block, supraventricular tachycardia and grossly ischemic ST-T wave changes; what is the culprit?

open access: yesJEM Reports
Background: Hypokalemia is a common problem encountered in the emergency department. Severe cases of hypokalemia are associated with increased morbidity and mortality.
Mazen M. Kawji
doaj   +1 more source

Long‐term clinical trajectory of microvillus inclusion disease associated with STXBP2‐related familial hemophagocytic lymphohistiocytosis type 5: A case report

open access: yesJournal of Parenteral and Enteral Nutrition, Volume 50, Issue 7, Page 1040-1044, October 2026.
Abstract Familial hemophagocytic lymphohistiocytosis type 5 is caused by biallelic pathogenic variants in STXBP2, which encodes syntaxin‐binding protein, a key regulator of vesicle trafficking. In addition to immune dysregulation, patients with familial hemophagocytic lymphohistiocytosis type 5 may present with severe, persistent diarrhea associated ...
Hiroyuki Tanaka   +5 more
wiley   +1 more source

Real-World Evidence on Levetiracetam-Induced Hypokalemia: An Active Comparator Cohort Study

open access: yesDrugs - Real World Outcomes
Background Levetiracetam is an anti-seizure medication (ASM) with an established safety profile. However, a potential safety signal of hypokalemia following levetiracetam use was published in the World Health Organization newsletter.
Ohoud Almadani   +5 more
doaj   +1 more source

Hypokalemia in hospitalized patients with pneumonia associated with COVID-19

open access: yes, 2021
Background. In 5–20 % cases, a new coronavirus infection (COVID-19) can cause pneumonia and require hospitalization. There is a high incidence of hypokalemia among hospitalized patients with COVID-19. Objective.
Tsiberkin A.I.
core  

Hypertriglyceridemia: Causes, Consequences, Diagnosis, and Management

open access: yesMedComm, Volume 7, Issue 10, October 2026.
Hypertriglyceridemia (HTG) arises from the interplay between genetic susceptibility and secondary or precipitating factors, leading to dysregulated triglyceride‐rich lipoprotein (TRL) metabolism. Increased TRL production and impaired clearance promote distinct risk phenotypes: accumulation of apolipoprotein B(apoB)‐containing TRL remnants contributes ...
Shanshan Qi   +9 more
wiley   +1 more source

A Team‐Based Patient Engagement Approach to Selexipag Initiation and Maintenance in Pulmonary Arterial Hypertension (TEAM PAH): Real‐World Dosing Patterns and Persistence Among Patients With and Without a History of Methamphetamine Use

open access: yesPulmonary Circulation, Volume 16, Issue 4, October 2026.
ABSTRACT Selexipag is an oral prostacyclin receptor agonist approved for pulmonary arterial hypertension (PAH). This single‐center, retrospective study described oral selexipag dosing patterns and persistence, overall and stratified by history of methamphetamine (meth) use, at an expert center in California, USA, using a multidisciplinary, nurse ...
Samuel B. Brusca   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy